Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...

Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...

September is recognized as Ovarian Cancer Awareness Month. But, do you know the signs and symptoms that could be impacting ...

September is Ovarian Cancer Awareness Month and two local survivors want others to know about the early warning signs of this ...

Ovarian cancer is a type of cancer that impacts the female reproductive system. The risk of developing ovarian cancer in a woman's lifetime is 1 in 87, according to the American Cancer Society (ACS).

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

Research has found 78% of women in the UK do not know the signs and symptoms of the five gynaecological cancers.

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

BLUE ASH, Ohio (WKRC) - An event this weekend in Blue Ash will help support cancer survivors. The Teal Power 5K Run and Walk to Fight Ovarian Cancer is Saturday. Everyone is invited to join hundreds ...

Happy 50th “SNL!" The NBC sketch comedy mainstay “Saturday Night Live” begins its 50th season Sept. 28. Over the decades, ...